These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25745990)

  • 41. Relationship between statin type and responsiveness to clopidogrel in patients treated with percutaneous coronary intervention: a subgroup analysis of the CILON-T trial.
    Suh JW; Cha MJ; Lee SP; Chae IH; Bae JH; Kwon TG; Bae JW; Cho MC; Rha SW; Kim HS
    J Atheroscler Thromb; 2014; 21(2):140-50. PubMed ID: 24140730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rosuvastatin Lowers Systemic Inflammatory Response in Coronary Artery Bypass Graft Accompanied by Cardiopulmonary Bypass Surgery: A Randomized Controlled Study.
    Ozguler IM; Burma O; Uysal A; Akbulut H
    Clin Invest Med; 2015 Aug; 38(4):E154-63. PubMed ID: 26278425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Rosuvastatin on Apolipoprotein J in Balloon-Injured Carotid Artery in Rats.
    Yang N; Dong B; Yang J; Li Y; Kou L; Liu Y; Qin Q
    Arq Bras Cardiol; 2018 Oct; 111(4):562-568. PubMed ID: 30281685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of renal function on changes of plaque characteristics in non-intervened coronary segments after rosuvastatin treatment in patients with angina pectoris and hypertension.
    Hong YJ; Jeong MH; Cho KH; Kim MC; Lee KJ; Kim KH; Kim HK; Jeong HC; Park KH; Sim DS; Kim JH; Ahn Y; Cho JG; Park JC; Kim SH; Kang JC
    Int J Cardiol; 2015; 187():286-7. PubMed ID: 25838233
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes.
    Miyazaki Y; Katanasaka Y; Sunagawa Y; Hirano-Sunagawa S; Funamoto M; Morimoto E; Komiyama M; Shimatsu A; Satoh-Asahara N; Yamakage H; Wada H; Hasegawa K; Morimoto T
    Int J Cardiol; 2016 Dec; 225():332-336. PubMed ID: 27756037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
    Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
    Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
    Haver VG; Mateo Leach I; Kjekshus J; Fox JC; Wedel H; Wikstrand J; de Boer RA; van Gilst WH; McMurray JJ; van Veldhuisen DJ; van der Harst P
    Eur J Heart Fail; 2015 Mar; 17(3):313-9. PubMed ID: 25639660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.
    Li L; Zhang M; Su F; Li Y; Shen Y; Shen J; Zhang D
    Lipids Health Dis; 2015 Feb; 14():10. PubMed ID: 25879728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
    Schwartz GG; Bessac L; Berdan LG; Bhatt DL; Bittner V; Diaz R; Goodman SG; Hanotin C; Harrington RA; Jukema JW; Mahaffey KW; Moryusef A; Pordy R; Roe MT; Rorick T; Sasiela WJ; Shirodaria C; Szarek M; Tamby JF; Tricoci P; White H; Zeiher A; Steg PG
    Am Heart J; 2014 Nov; 168(5):682-9. PubMed ID: 25440796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study.
    Os HA; Rollefstad S; Gerdts E; Kringeland E; Ikdahl E; Semb AG; Midtbø H
    Rheumatology (Oxford); 2020 Dec; 59(12):3700-3708. PubMed ID: 32386421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome.
    Toso A; De Servi S; Leoncini M; Angiolillo DJ; Calabrò P; Piscione F; Cattaneo M; Maffeo D; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Genereux P; Bellandi F; Barozzi C; Tomasi L; Della Riva D; Palmerini T
    J Thromb Thrombolysis; 2017 Oct; 44(3):355-361. PubMed ID: 28840456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.
    Thondapu V; Kurihara O; Yonetsu T; Russo M; Kim HO; Lee H; Soeda T; Minami Y; Jang IK
    Am J Cardiol; 2019 May; 123(10):1565-1571. PubMed ID: 30851941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).
    Kaya A; Kurt M; Tanboğa IH; Işik T; Ekinci M; Aksakal E; Kaya Y; Topçu S; Sevimli S
    Acta Cardiol; 2013 Oct; 68(5):489-94. PubMed ID: 24283110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis.
    San Norberto EM; Gastambide MV; Taylor JH; García-Saiz I; Vaquero C
    Vasa; 2016; 45(2):133-40. PubMed ID: 27058799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.
    Ghazeeri G; Abbas HA; Skaff B; Harajly S; Awwad J
    J Endocrinol Invest; 2015 Jun; 38(6):643-51. PubMed ID: 25722221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
    Birnbaum Y; Birnbaum GD; Birnbaum I; Nylander S; Ye Y
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):539-550. PubMed ID: 27830382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-dependent INhibitory effect of rosuVastatin In Japanese patienTs with Acute myocardial infarcTION on serum concentration of matrix metalloproteinases - INVITATION trial.
    Fujisue K; Shirakawa T; Nakamura S; Yamamoto N; Oshima S; Matsumura T; Tsunoda R; Hirai N; Tayama S; Nakamura N; Hirose T; Maruyama H; Fujimoto K; Kajiwara I; Sakamoto T; Nakao K; Sakaino N; Hokimoto S; Nagayoshi Y; Hokamaki J; Shimomura H; Sakamoto K; Yamamoto E; Izumiya Y; Kaikita K; Ogawa H; Tsujita K;
    J Cardiol; 2018 Oct; 72(4):350-355. PubMed ID: 29735336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Randomized Trial of Creatine-kinase Leak After Rosuvastatin in Elective Percutaneous Coronary Intervention (CLEAR-PCI).
    Martins KB; Mattos LA; Sousa AG; Sousa JE; Abzaid A; Feres F; de Ribamar JC; Staico R; Costa RA; Chaves AJ
    J Interv Cardiol; 2015 Aug; 28(4):339-47. PubMed ID: 26086603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.